[go: up one dir, main page]

KR960000195A - Hair growth agents - Google Patents

Hair growth agents Download PDF

Info

Publication number
KR960000195A
KR960000195A KR1019950016329A KR19950016329A KR960000195A KR 960000195 A KR960000195 A KR 960000195A KR 1019950016329 A KR1019950016329 A KR 1019950016329A KR 19950016329 A KR19950016329 A KR 19950016329A KR 960000195 A KR960000195 A KR 960000195A
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
combination
carbon
sum
Prior art date
Application number
KR1019950016329A
Other languages
Korean (ko)
Inventor
겐지 쓰지하라
구니오 사이토
사토시 후루우치
Original Assignee
지바타 이치로
다나베세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지바타 이치로, 다나베세이야쿠 가부시키가이샤 filed Critical 지바타 이치로
Publication of KR960000195A publication Critical patent/KR960000195A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 활성 성분으로서 다음 일반식(Ⅰ)의 카르니틴 화합물을 포함하는 모발 성장(회복)제에 관한 것이다.The present invention relates to a hair growth (recovery) agent comprising a carnitine compound of the following general formula (I) as an active ingredient.

상기식에서, R1내지 R3은 각각 타소수 1내지6의 알킬 그룹이고, R4은 치환될 수 있는 탄소수 3내지 31의 지방족 아실 그룹이며, R5는 치환될 수도 있는 탄소수 3내지 31의 알칼 그룹 또는 치환될 수도 있는 탄소수 3내지 31의 알케닐 그룹이고, X는 약제학적으로 허용되는 산의 음이온이다.Wherein R 1 to R 3 are each an alkyl group having 1 to 6 carbon atoms, R 4 is an aliphatic acyl group having 3 to 31 carbon atoms which may be substituted, and R 5 is an alkyl having 3 to 31 carbon atoms which may be substituted Group or an alkenyl group having 3 to 31 carbon atoms which may be substituted, X is an anion of a pharmaceutically acceptable acid.

Description

모발 성장제Hair growth agents

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (18)

활성 성분으로서 다음 일반식(Ⅰ)의 카르니틴 화합물을 포함하는 모발 성장제:Hair growth agents comprising the carnitine compound of the general formula (I) as the active ingredient: 상기식에서, R1내지 R3은 각각 탄소수 1내지 6의 알킬 그룹이고, R4은 치환될 수도 있는 탄소수 3내지 31의 지방족 아실 그룹이며, R5는 치환될 수도 있는 탄소수 3내지 31의 알킬 그룹 또는 치환될 수도 있는 탄소수 3내지 31의 알케닐 그룹이고, X는 약제학적으로 허용되는 산이 음이온이다.Wherein R 1 to R 3 are each an alkyl group having 1 to 6 carbon atoms, R 4 is an aliphatic acyl group having 3 to 31 carbon atoms which may be substituted, and R 5 is an alkyl group having 3 to 31 carbon atoms which may be substituted Or an alkenyl group having 3 to 31 carbon atoms which may be substituted, X is a pharmaceutically acceptable acid is an anion. 제1항에 있어서, R1내지 R3이 각각 탄소수 1내지 6의 알킬 그룹이고, R4가 히이드록시 그룹 및 탄소수 2내지 7의 알콕시카보닐 그룹으로 이루어진 그룹 중에서 선택된 치환제를 가질수 있는, 탄소수 3내지 31의 지방족 아실 그룹이며, R5가 하이드록시 그룹 및 탄소수 2내지 7의 알콕시카보닐 그룹으로 이루어진 그룹중에서 선택된 치환제를 가질 수 있는, 탄소수 3 내지 31의 알킬 그룹, 또는 하이도록시 그룹 및 탄소수 2내지 7의 알콕시카보닐 그룹으로 이루어진 그룹 중에서 선택된 치환제를 가질 수 있는, 탄소수 3 내지 31의 알케닐 그룹인 모발 성장제.The compound of claim 1, wherein R 1 to R 3 are each an alkyl group having 1 to 6 carbon atoms, and R 4 may have a substituent selected from the group consisting of a hydroxy group and an alkoxycarbonyl group having 2 to 7 carbon atoms. An aliphatic acyl group having 3 to 31 carbon atoms, wherein R 5 may have a substituent selected from the group consisting of a hydroxy group and an alkoxycarbonyl group having 2 to 7 carbon atoms, or a hygioxy group A hair growth agent which is an alkenyl group having 3 to 31 carbon atoms, which may have a substituent selected from the group consisting of a group and an alkoxycarbonyl group having 2 to 7 carbon atoms. 제1항에 있어서, R1내지 R3이 각각 탄소수 1내지 6의 알킬 그룹이고, R4가 탄소수 수 3내지 31의 지방족 아실 그룹이며, R5가 탄소수 3내지 31의 알킬그룹 또는 탄소수 3내지 31의 알케닐 그룹인 모발 성장제.The compound of claim 1, wherein R 1 to R 3 are each an alkyl group having 1 to 6 carbon atoms, R 4 is an aliphatic acyl group having 3 to 31 carbon atoms, and R 5 is an alkyl group having 3 to 31 carbon atoms or 3 to 3 carbon atoms. Hair growth agent, which is an alkenyl group of 31. 제3항에 있어서, R1내지 R3이 각각 메틸 그룹, 에틸그룹, 프로필 그룹, 부틸 그룹, 펜틸 그룹 또는 헥실 그룹이고, R4가 프로피오닐 그룹, 부티릴 그룹, 이소부티릴 그룹, 크로토노일 그룹, 메타그릴로일 그룹, 발레릴 그룹, 이소발레릴 그룹, 피발로일 그룹, 헥사노일 그룹, 4-메탈벨레릴 그룹, 소르비노일 그룹, 헵타노일 그룹, 옥타노일 그룹, 2-프로필발레릴 그룹, 노나노일 그룹, 데카노일 그룹, 운데카노일 그룹, 10-운데카노일 그룹, 도데카노일 그룹, 트리데카노일 그룹, 테트라데카노일 그룹, 펜타카노일 그룹, 헥사데카노일 그룹, 헵타데카노일 그룹, 옥타데카노일 그룹, 올레오일 그룹, 엘라이도일 그룹, 리놀레오일 그룹, 리놀레노일그룹, 노나데카노일 그룹, 2,6,10,14-테트라메틸펜타데카노일 그룹, 이코사노일 그룹, 3,7,11,15-테트라메틸헥사데카노일 그룹, 아라키도일 그룹, 헤네이코사노일 그룹, 도코사노일 그룹, 토리코사노일 그룹, 테트라코사노일 그룹, 펜타코사노일 그룹, 헥사코사노일 그룹, 헵타코사노일 그룹, 옥사코사노일 그룹, 노나코사노일 그룹, 트리아콘타노일 그룹 또는 헨트리아콘타노일 그룹이며, R5가 프로필 그룹, 이소프로필 그룹, 부틸 그룹, 이소부틸 그룹, 1-메틸프로필 그룹, 1,1-디메틸에틸 그룹, 펜틸 그룹, 메틸부틸 그룹, 2-메틸부틸 그룹, 3-메틸부틸 그룹, 1,1-디메틸프로필 그룹, 1,2-디메틸프로필 그룹, 2,2-디메틸프로필 그룹, 1-에틸프로필 그룹, 2-에틸프로필 그룹, 핵실 그룹, 이소헥실 그룹, 1-메틸펜틸 그룹, 2-메틸펜틸 그룹, 3-메틸펜틸 그룹, 1-에틸부틸 그룹, 2-에틸부틸 그룹, 1,1-디메틸부틸 그룹, 1,2-디메틸부틸 그룹, 1,3-디메틸 부틸 그룹, 2,2-디메틸부틸 그룹, 2,3-디메틸부틸 그룹, 3,3-디메틸부틸 그룹, 1-에틸-1-메틸프로필 그룹, 1-에틸-2-메틸프로필 그룹, 2-에틸-1-메틸프로필 그룹, 2-에틸-2-메틸프로필 그룹, 1-메틸-2-에틸프로필 그룹, 1,1,2-트리메틸프로필 그룹, 1,2,2-트리메틸프로필 그룹, 헵틸 그룹, 옥틴 그룹, 2-프로필펜틸 그룹, 노닐 그룹, 데실 그룹, 운데실 그룹, 도데실 그룹, 트리데실 그룹, 테트라데실 그룹, 펜타데실 그룹, 헥사데실 그룹, 헵타데실 그룹, 옥타데실 그룹, 노나데실 그룹, 이코실 그룹, 헨에이코실 그룹, 도코실 그룹, 트리코실 그룹, 테트라코실 그룹, 펜타코실 그룹, 헥사코실 그룹, 헵타코실 그룹, 옥타코실 그룹,노나코실 그룹, 트리아콘틸 그룹 또는 헨트리아콘틸 그룹, 또는 2-프로페닐 그룹, 1-메틸에니티닐 그룹,10-운데세닐 그룹, 14-펜타데세닐 그룹, 3,7,11,15-테트라메틸-2-헥사데세닐 그룹, 20-헨에이코세닐 그룹 또는 30-헨트리아콘테닐 그룹이고, X가 클로라이드, 아세테이트, 시트레이트, 니코티네이트, 니트레이트, 설포네이트, 및 살리실리레이트로 이루어진 그룹 중에서 선택된 약제학적으로 허용되는 산의 음이온인 모발 성장제.4. A compound according to claim 3, wherein R 1 to R 3 are each methyl group, ethyl group, propyl group, butyl group, pentyl group or hexyl group, and R 4 is propionyl group, butyryl group, isobutyryl group, crotono Il group, methacryloyl group, valeryl group, isovaleryl group, pivaloyl group, hexanoyl group, 4-metalbeleryl group, sorbinoyl group, heptanoyl group, octanoyl group, 2-propylvalle Reel group, nonanoyl group, decanoyl group, undecanoyl group, 10-undecanoyl group, dodecanoyl group, tridecanoyl group, tetradecanoyl group, pentacanoyl group, hexadecanoyl group, hepta Decanoyl group, octadecanoyl group, oleoyl group, elliodoyl group, linoleoyl group, linolenoyl group, nonadecanoyl group, 2,6,10,14-tetramethylpentadecanoyl group, isocano Group, 3,7,11,15-tetramethylhexadecanoyl Group, arachidyl group, henecosanoyl group, docosanoyl group, toricosanoyl group, tetracosanoyl group, pentacosanoyl group, hexacosanoyl group, heptacosanoyl group, oxacosanoyl group, nona A cosanoyl group, a triacontanoyl group, or a heteroacontanoyl group, R 5 is a propyl group, isopropyl group, butyl group, isobutyl group, 1-methylpropyl group, 1,1-dimethylethyl group, pentyl Group, methylbutyl group, 2-methylbutyl group, 3-methylbutyl group, 1,1-dimethylpropyl group, 1,2-dimethylpropyl group, 2,2-dimethylpropyl group, 1-ethylpropyl group, 2- Ethylpropyl group, nuclear chamber group, isohexyl group, 1-methylpentyl group, 2-methylpentyl group, 3-methylpentyl group, 1-ethylbutyl group, 2-ethylbutyl group, 1,1-dimethylbutyl group, 1 , 2-dimethylbutyl group, 1,3-dimethyl butyl group, 2,2-dimethylbutyl group, 2,3-dimethyl moiety Tyl group, 3,3-dimethylbutyl group, 1-ethyl-1-methylpropyl group, 1-ethyl-2-methylpropyl group, 2-ethyl-1-methylpropyl group, 2-ethyl-2-methylpropyl group , 1-methyl-2-ethylpropyl group, 1,1,2-trimethylpropyl group, 1,2,2-trimethylpropyl group, heptyl group, octin group, 2-propylpentyl group, nonyl group, decyl group, undecylenate Cilyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group, hexadecyl group, heptadecyl group, octadecyl group, nonadecyl group, ecoxyl group, henacyl group, docosyl group, tricosyl Group, tetracosyl group, pentacosyl group, hexacosyl group, heptacosyl group, octacosyl group, nonacosyl group, triacontyl group or gentriacontyl group, or 2-propenyl group, 1-methyl Nitinyl group, 10-undecenyl group, 14-pentadesenyl group, 3,7,11,15-tetramethyl-2-hexadecenyl group, 20-henei Hair which is a senyl group or a 30-hentriacontenyl group and X is an anion of a pharmaceutically acceptable acid selected from the group consisting of chloride, acetate, citrate, nicotinate, nitrate, sulfonate, and salicylate Growth agents. 제1항에 있어서, R1내지 R3이 각각 탄소수 1내지 4의 알킬 그룹이고, R4가 탄소수 수 3내지 18의 지방족 아실 그룹이며, R5가 탄소수 3내지 21의 알킬그룹 또는 탄소수 3내지 21의 알케닐 그룹인 모발 성장제.The compound of claim 1, wherein R 1 to R 3 are each an alkyl group having 1 to 4 carbon atoms, R 4 is an aliphatic acyl group having 3 to 18 carbon atoms, and R 5 is an alkyl group having 3 to 21 carbon atoms or 3 to C 3. Hair growth agent which is an alkenyl group of 21. 제5항에 있어서, R1내지 R3이 각각 메틸 그룹이고, R4가 프로피오닐 그룹, 이소부터릴 그룹, 발레릴그룹, 헥사노일 그룹, 4-메틸발레릴 그룹, 헵타노일 그룹, 2-프로필발레릴 그룹, 노나노일 그룹, 운데가코일그룹, 10-운데세노일 그룹, 트리데카노일 그룹, 테트라데카노일 그룹, 펜타데카노일 그룹, 헥사데카노일 그룹, 헵타데카노일 그룹 또는 리놀레오일 그룹이고, R5가 프로필 그룹,펜틸 그룹, 2-메틸부틸 그룹, 이소헥실 그룹, 헵틸 그룹, 노닐그룹, 데실 그룹, 운데실 그룹, 도데실 그룹, 트리데실 그룹, 테트라데실 그룹, 펜타데실 그룹, 헨에이코실 그룹 또는 10-운데세닐 그룹인 모발 성장제.6. A compound according to claim 5, wherein R 1 to R 3 are each methyl group, R 4 is propionyl group, isobornyl group, valeryl group, hexanoyl group, 4-methylvaleryl group, heptanoyl group, 2- Propylvaleryl group, nonanoyl group, undecoil group, 10-undecenoyl group, tridecanoyl group, tetradecanoyl group, pentadecanoyl group, hexadecanoyl group, heptadecanoyl group or linoleoyl R 5 is a propyl group, pentyl group, 2-methylbutyl group, isohexyl group, heptyl group, nonyl group, decyl group, undecyl group, dodecyl group, tridecyl group, tetradecyl group, pentadecyl group Hair growth agents which are a Henecosyl group or a 10-Undecenyl group. 제1항에 있어서, R1내지 R3이 각각 탄소수 1내지 4의 알킬 그룹이고, R4가 탄소수 3내지 15의 지방족 아실 그룹이며, R5가 탄소수 3내지 15의 알킬그룹 또는 탄소수 3내지 15의 알케닐 그룹인 모발 성장제.The compound according to claim 1, wherein R 1 to R 3 are each an alkyl group having 1 to 4 carbon atoms, R 4 is an aliphatic acyl group having 3 to 15 carbon atoms, and R 5 is an alkyl group having 3 to 15 carbon atoms or 3 to 15 carbon atoms. Hair growth agents which are alkenyl groups. 제7항에 있어서, R1내지 R3이 각각 메틸 그룹이고, R4가 프로피오닐 그룹, 이소부터릴 그룹, 발레릴그룹, 헥사노일 그룹, 4-메틸발레릴 그룹, 헵타노일 그룹,운데카노일 그룹, 10-운데세노일 그룹, 트리데카 노일 그룹 또는 펜타데카노일 그룹이고, R5가 프로필 그룹, 펜틸 그룹, 2-메틸부틸 그룹, 헵틸 그룹, 노닐 그룹, 운데실 그룹, 도데실 그룹, 트리데실 그룹, 테트라델실 그룹 또는 펜타데실 그룹인 모발 성장제.8. A compound according to claim 7, wherein R 1 to R 3 are each methyl group, R 4 is propionyl group, isobornyl group, valeryl group, hexanoyl group, 4-methylvaleryl group, heptanoyl group, undecano 1 group, 10-undecenoyl group, tridecanoyl group or pentadecanoyl group, R 5 is propyl group, pentyl group, 2-methylbutyl group, heptyl group, nonyl group, undecyl group, dodecyl group, Hair growth agents that are tridecyl group, tetradelyl group, or pentadecyl group. 제1항에 있어서, R1내지 R3이 각각 탄소수 1내지 6의 알킬 그룹이고, R4가 탄소수 4내지 31의 지방족 아실 그룹이며, R5가 탄소수 11내지 31의 알킬그룹인 모발 성장제.The hair growth agent according to claim 1, wherein R 1 to R 3 are each an alkyl group having 1 to 6 carbon atoms, R 4 is an aliphatic acyl group having 4 to 31 carbon atoms, and R 5 is an alkyl group having 11 to 31 carbon atoms. 제1항에 있어서, R4의 지방족 아실 잔기의 탄소수와 R5의 알킬 잔기 또는 알케닐 잔기의 탄소수의 합이 6내지 34인 모발 성장제.The hair growth agent according to claim 1, wherein the carbon number of the aliphatic acyl residue of R 4 and the carbon number of the alkyl or alkenyl residue of R 5 are 6 to 34. 제3항에 있어서, R4의 탄소수와 R5의 탄소수의 합이 6 내지 34인 모발 성장제.The hair growth agent of Claim 3 whose sum of carbon number of R <4> and carbon number of R <5> is 6-34. 제11항에 있어서, R4의 탄소수와 R5의 탄소수의 조합이(1) 탄소수의 합이 6인 경우에는 R4의 탄소수가 3이고 R5의 탄소수가 3인 조합:(2)탄소수 합이 8인 경우에는, R4의 탄소수가 5이고 R5의 탄소수가 3인 조합;(3)탄소수 합이 12인 경우에는, R4의 탄소수가 5이고 R5의 탄소수가 7인 조합;(4)탄소수 합이 14인 경우에는, R4의 탄소수가 3이고 R5의 탄소수가 11인 조합 또는 R4의 탄소수가 11이고 R5의 탄소수가 3인 조합;(5)탄소수 합이 15인 경우에는, R4의 탄소수가 4이고 R5의 탄소수가 11인 조합;(6)탄소수 합이 16인 경우에는, R4의 탄소수가 3이고 R5의 탄소수가 13인 조합, R4의 탄소수가 5이고 R5의 탄소수가 11인 조합, R4의 탄소수가 7이고 R5의 탄소수가 9인 조합, R4의 탄소수가 11이고 R5의 탄소수가 5인 조합,R4의 탄소수가 13이고 R5의 탄소수가 3인 조합;(7)탄소수 합이 17인 경우에는, R4의 탄소수가 4이고 R5의 탄소수가 13인 조합, R4의 탄소수가 5이고 R5의 탄소수가 12인 조합, R4의 탄소수가 6이고 R5의 탄소수가 12인 조합 또는 R4의 탄소수가 6이고 R5의 탄소수가 11인 조합;(8)탄소수 합이 18인 경우에는, R4의 탄소수가 3이고 R5의 탄소수가 15인 조합, R4의 탄소수가 4이고 R5의 탄소수가 14인 조합, R4의 탄소수가 5이고 R5의 탄소수가 13인 조합 또한 R4의 탄소수가 6이고 R5의 탄소수가 12인 조합,R4의 탄소수가 7이고 R5의 탄소수가 11인 조합, R4의 탄소수가 9이고 R5의 탄소수가 9인 조합, R4의 탄소수가 11이고 R5의 탄소수가 7인 조합, R4의 탄소수가 13이고 R5의 탄소수가 5인 조합,또한 R4의 탄소수가 15이고 R5의 탄소수가 3인 조합;(9)탄소수 합이 19인 경우에는, R4의 탄소수가 4이고 R5의 탄소수가 15인 조합, R4의 탄소수가 6이고 R5의 탄소수가 13인 조합, R4의 탄소수가 8이고 R5의 탄소수가 11인 조합 또한 R4의 탄소수가 11이고 R5의 탄소수가8인 조합,R4의 탄소수가 13이고 R5의 탄소수가 6인 조합, R4의 탄소수가 15이고 R5의 탄소수가 4인 조합, R4의 탄소수가 16이고 R5의 탄소수가 3인 조합;(10)탄소수 합이 20인 경우에는, R4의 탄소수가 5이고 R5의 탄소수가 15인 조합, R4의 탄소수가 7이고 R5의 탄소수가 13인 조합, R4의 탄소수가 9이고 R5의 탄소수가 11인 조합 또한 R4의 탄소수가 11이고 R5의 탄소수가 9인 조합 또는R4의 탄소수가 13이고 R5의 탄소수가 7인 조합;(11)탄소수의 합이 21인 경우에는, R4의 탄소수가 8이고 R5의 탄소수가 13인 조합, R4의 탄소수가 16이고 R5의 탄소수가 5인 조합 또는 R4의 탄소수가 18이고 R5의 탄소수가 3인 조합;(12)탄소수의 합이 22인 경우에는, R4의 탄소수가 11이고 R5의 탄소수가 11인 조합, R4의 탄소수가 7이고 R5의 탄소수가 15인 조합 또는R4의 탄소수가 13이고 R5의 탄소수가 9인 조합;(13)탄소수의 합이 23인 경우에는, R4의 탄소수가 8이고 R5의 탄소수가 15인 조합;(14)탄소수의 합이 25인 경우에는, R4의 탄소수가 13이고 R5의 탄소수가 12인 조합,R4의 탄소수가 14이고 R5의 탄소수가 11인 조합 또는 R4의 탄소수가 16이고 R5의 탄소수가 9인 조합;(15)탄소수의 합이 26인 경우에는, R4의 탄소수가 13이고 R5의 탄소수가 13인 조합, 또는 R4의 탄소수가 14이고 R5의 탄소수가 11인 조합;(16)탄소수의 합이 27인 경우에는, R4의 탄소수가 16이고 R5의 탄소수가 11인 조합;(17)탄소수의 합이 28인 경우에는, R4의 탄소수가 15이고 R5의 탄소수가 13인 조합,R4의 탄소수가 17이고 R5의 탄소수가 11인 조합 또는 R4의 탄소수가 16이고 R5의 탄소수가 12인 조합;(18)탄소수의 합이 30인 경우에는, R4의 탄소수가 15이고 R5의 탄소수가 15인 조합;및 (19)탄소수의 합이 34인 경우에는, R4의 탄소수가 13이고 R5의 탄소수가 21인 조합으로 이루어진 그룹 중에서 선택되는 모발 성장제.12. The combination according to claim 11, wherein the combination of carbon number of R 4 and carbon number of R 5 is (1) when the sum of carbon number is 6, the carbon number of R 4 is 3 and the carbon number of R 5 is (2) In the case of 8, a combination of 5 carbon atoms in R 4 and 3 carbon atoms in R 5 ; (3) In the case of 12 carbon atoms, a combination of 5 carbon atoms in R 4 and 7 carbon atoms in R 5 ; ( 4) in the case of carbon number of the sum is 14, the R 4 the number of carbon atoms is 3, and R 5 of the carbon atoms is 11 for the number of carbon atoms is 11, a combination, or R 4 and a have the R 5 having up to 3 carbon atoms in combination; 5 carbon atoms, the sum of 15 case, the carbon number is four and the number of carbon atoms is 11, a combination of R 5 for R 4; in the case of 6 carbon atoms, the sum is 16, the R 4 the number of carbon atoms is 3, and of R 5 a carbon number of 13 in combination, the number of carbon atoms of R 4 Is 5 and R 5 has 11 carbon atoms, R 4 has 7 carbon atoms and R 5 has 9 carbon atoms, R 4 has 11 carbon atoms and R 5 carbon atoms 13, R 4 has 13 carbon atoms carbon atoms of R 5 3 in combination, (7) in the case of carbon atoms, the sum is 17, in the R 4 the number of carbon atoms is 4, and that of R 5 carbon atoms, 13 combinations, of R 4 the number of carbon atoms is 5 and a is of the R 5 12 carbon atoms in combination, R 4 A combination having 6 carbon atoms and 12 carbon atoms for R 5 , or a carbon number 6 for R 4 and 11 carbon atoms for R 5 ; (8) if the carbon number sum is 18, the carbon number for R 4 is 3 and for R 5 A combination of 15 carbon atoms, a combination of 4 carbon atoms in R 4 , 14 carbon atoms in R 5 , a combination of 5 carbon atoms in R 4 , and 13 carbon atoms in R 5 , and also a carbon number of R 4 and a carbon number of R 5 12 in combination, R 4 the number of carbon atoms is 7, and R 5 in carbon number is 11 in combination, R 4 having the carbon number of 9 and R 5 having the carbon number of 9 combinations, R 4 having the carbon number of 11 and of R 5 having 7 of the of Combination, a combination of 13 carbon atoms of R 4 and 5 carbon atoms of R 5 , and of 15 carbon atoms of R 4 and 3 carbon atoms of R 5 ; (9) in the case of 19 carbon atoms, the carbon number of R 4 end Combinations of 4 and R 5 having 15 carbon atoms, combinations of R 4 having 6 carbon atoms and R 5 having 13 carbon atoms, combinations of R 4 having 8 carbon atoms and R 5 having 11 carbon atoms, R 4 having 11 carbon atoms R 5 in carbon number is 8, the combination of R 4 of the carbon atoms 13 and R 5 of the carbon atoms is 6, a combination of R 4 the number of carbon atoms is 15, and R 5 having the carbon number of 4 or a combination of, carbon number 16 of R 4 and R 5 (10) when the carbon number sum is 20, a combination of 5 carbon atoms of R 4 and 15 carbon atoms of R 5 , a combination of 7 carbon atoms of R 4 and 13 carbon atoms of R 5 , A combination of 9 carbon atoms in R 4 and 11 carbon atoms in R 5 , or a combination of 11 carbon atoms in R 4 and 9 carbon atoms in R 5 or a carbon number 13 in R 4 and 7 carbon atoms in R 5 ; (11 ) carbon atoms in the case of the sum of the carbon atoms is 21, the carbon number of R 4 is 8 and the carbon number of R 5 is 13, a combination, the number of carbon atoms of R 4 and R 5 16 carbon atoms is 5 or a combination of R 4 18 and is of the R 5 having up to 3 carbon atoms in combination; the case of 12, the sum of carbon number 22,, R 4 of the carbon atoms 11 and R 5 of the carbon atoms is 11, a combination, R 4 the number of carbon atoms is 7, and the number of carbon atoms of R 5 Is a combination of 15 or a combination of 13 carbon atoms in R 4 and 9 carbon atoms in R 5 ; (13) when the sum of carbon atoms is 23, a combination of 8 carbon atoms in R 4 and 15 carbon atoms in R 5 ; ( 14) If the sum of the carbon number of 25 is, R 4 of the carbon atoms 13 and R 5 of the carbon atoms 12 in combination, R 4 of the carbon atoms is 14, and R 5 having the carbon number of 16 in the carbon number is 11 in combination or R 4 of R 5 a carbon number of 9 in combination; if (15) the sum of the carbon number of 26 is, in R 4, the carbon number is 13 and is in R 5 a carbon number of 13, a combination, or the R number of carbon atoms is 14, 4 and of R 5 carbon atoms A combination of 11; (16) when the sum of carbon atoms is 27, a combination of 16 carbon atoms in R 4 and 11 carbon atoms in R 5 ; (17) when the sum of carbon atoms is 28, 15 carbon atoms in R 4 And R 5 A combination of 13 carbon atoms, a combination of 17 carbon atoms of R 4 , 11 carbon atoms of R 5 , or a combination of 16 carbon atoms of R 4 , and 12 carbon atoms of R 5 ; (18) , A combination of 15 carbon atoms of R 4 and 15 carbon atoms of R 5 ; and (19) when the sum of carbon atoms is 34, a combination of 13 carbon atoms of R 4 and 21 carbon atoms of R 5 . Hair growth agent. 제12항에 있어서, R4의 탄소수와 R5의 탄소수의 합이 14내지 26인 모발 성장제.The hair growth agent according to claim 12, wherein the carbon number of R 4 and the carbon number of R 5 are 14 to 26. 제1항 내지 제13항중 어느 한 항에 있어서, 남성형 탈모증, 노인성 탈모증, 탈로젠 탈모 및 백모증 예방 및 치료제로서의 모발 성장제.The hair growth agent according to any one of claims 1 to 13, as a prophylactic and therapeutic agent for androgenetic alopecia, senile alopecia, talogen alopecia and leukemia. 다음 일반식(Ⅰ)의 카르니틴 화합물.Carnitine compound of the following general formula (I). 상기식에서, R1내지R3은 각각 메틸 그룹이고, R4및 R5는 다음의 조합, 즉 R4는 다음의 조합, 즉 R4는 펜타데카노일 그룹이고, R5는 운데실 그룹이며; R4는 발레릴 그룹이고, R5는 트리데실 그룹이며; R4는 프로피오닐 그룹이고, R5는 운데실 그룹이며, R4는 트리데카노일 그룹이고, R5는 펜틸그룹이며; R4는 헵타노일 그룹이고, R5는 노닐 그룹이며; R4는 운데카노일 그룹이고, R5는 펜틸그룹이며;R4는 발레릴 그룹이고, R5는 운데실 그룹이며; R4는 운데카노일 그룹이고, R5는 헵틸 그룹이며; R4는 트리데카노일 그룹이고, R5는 헵틸 그룹이며; R4는 이소부티릴 그룹이고, R5는트리데실 그룹이며; R4는 프로피오닐 그룹이고, R5는트리데실 그룹이며; R4는 4-메틸발레릴 그룹이고, R5는 도데실 그룹이며; R4는 4-메틸발레릴 그룹이고, R5는트리데실 그룹이며; R4는 이소부티릴 그룹이고, R5는트리데실 그룹이며; R4는 발레릴 그룹이고, R5는 펜타데실 그룹이며; R4는 프로피오닐 그룹이고, R5는 펜타데실 그룹이며; 또는 R4는 헥사노일 그룹이고, R5는 운데실 그룹을 나타내며, X는 약제학적으로 허용되는 산의 음이온이다.Wherein R 1 to R 3 are each a methyl group, R 4 and R 5 are the following combinations, ie R 4 is the following combination, ie R 4 is a pentadecanoyl group and R 5 is an undecyl group; R 4 is valeryl group and R 5 is tridecyl group; R 4 is propionyl group, R 5 is undecyl group, R 4 is tridecanoyl group and R 5 is pentyl group; R 4 is a heptanoyl group and R 5 is a nonyl group; R 4 is an undecanoyl group, R 5 is a pentyl group; R 4 is a valeryl group and R 5 is an undecyl group; R 4 is an undecanoyl group and R 5 is a heptyl group; R 4 is a tridecanoyl group and R 5 is a heptyl group; R 4 is an isobutyryl group and R 5 is a tridecyl group; R 4 is propionyl group and R 5 is tridecyl group; R 4 is a 4-methylvaleryl group and R 5 is a dodecyl group; R 4 is a 4-methylvaleryl group and R 5 is a tridecyl group; R 4 is an isobutyryl group and R 5 is a tridecyl group; R 4 is a valeryl group and R 5 is a pentadecyl group; R 4 is propionyl group and R 5 is pentadecyl group; Or R 4 is a hexanoyl group, R 5 represents an undecyl group, and X is an anion of a pharmaceutically acceptable acid. 제15항에 있어서, 약제학적으로 허용되는 산의 음이온이 클로라이드, 아세테이트, 시트레이트, 니코티네이트, 니트레이트, 설포네이트 및 살리실레이트로 이루어진 그룹 중에서 선택된 음이온인 화합물.The compound of claim 15, wherein the anion of the pharmaceutically acceptable acid is an anion selected from the group consisting of chloride, acetate, citrate, nicotinate, nitrate, sulfonate and salicylate. 사람 또는 동물에서 모발 성장을 촉진시키는데 사용하기 위한, 제1항 내지 제13항중 어느 한 항에 따르는 제제의 용도.Use of an agent according to any one of claims 1 to 13 for use in promoting hair growth in humans or animals. 남성형 탈모증, 노인성 탈모증, 탈로젠 탈모 및 백모증의 예방 또는 치료에 사용하기 위한, 제1항 내지 제13항 중의 어느 한 항에 따르는 제제의 용도.Use of an agent according to any one of claims 1 to 13 for use in the prevention or treatment of androgenetic alopecia, senile alopecia, alopecia alopecia and leukemia. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950016329A 1994-06-20 1995-06-20 Hair growth agents KR960000195A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP94-136853 1994-06-20
JP13685394 1994-06-20
JP4271395 1995-03-02
JP95-042713 1995-03-02

Publications (1)

Publication Number Publication Date
KR960000195A true KR960000195A (en) 1996-01-25

Family

ID=26382444

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950016329A KR960000195A (en) 1994-06-20 1995-06-20 Hair growth agents

Country Status (6)

Country Link
US (1) US5741816A (en)
EP (1) EP0688555A3 (en)
KR (1) KR960000195A (en)
CN (1) CN1128139A (en)
AU (1) AU702532B2 (en)
CA (1) CA2152091A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980001977A (en) * 1996-06-29 1998-03-30 유충식 Fermentation composition for biological treatment of food waste and composting method
KR19980035281A (en) * 1996-11-11 1998-08-05 양대윤 Manufacturing method of fertilizer using waste

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274157B (en) * 1994-09-08 1997-07-15 Avantgarde Spa "L-CARNITINE SALT AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF SKIN DISEASES"
KR100499190B1 (en) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 Hair restorer
DE19631685A1 (en) * 1996-08-06 1998-02-12 Wella Ag Hydrolytically cleavable drug derivatives, hair treatment agents containing them and methods of treating hair
US6159950A (en) * 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth
DE10113446A1 (en) 2001-03-19 2002-09-26 Schwarzkopf Gmbh Hans Pharmaceutical or cosmetic hair treatment agents, especially for promoting hair growth, contain a betaine, especially carnitine, histidine, taurine, choline or betaine or their derivatives
WO2004078117A2 (en) * 2003-02-28 2004-09-16 E-L Management Corp. Method for increasing hair growth
US7223562B2 (en) * 2004-03-31 2007-05-29 New York University Compositions for controlling hair growth
DE102005011957A1 (en) * 2005-03-14 2006-12-07 Henkel Kgaa New hair treatment composition containing L-carnitine or L-carnitine derivatives
DE102005062356A1 (en) * 2005-12-23 2007-06-28 Henkel Kgaa Reduction of hair aging
EP2216321A1 (en) * 2009-02-05 2010-08-11 Lonza Ltd. Process for the production of a fatty acid/carnitine derivative
JP7312184B2 (en) 2017-10-23 2023-07-20 エピトラッカー インコーポレイテッド Fatty acid analogues and their use in treating symptoms associated with metabolic syndrome
JP2021525249A (en) 2018-05-23 2021-09-24 エピトラッカー インコーポレイテッドEpitracker, Inc. Compositions and Methods for Diagnosis and Treatment of Conditions Related to Aging and Long-Term Quality
FR3090343B1 (en) * 2018-12-20 2020-12-18 Oreal Process for treating keratin fibers using a composition comprising a salt of carnitine or of a carnitine derivative comprising an aromatic organic anion
CN110075035A (en) * 2019-06-10 2019-08-02 上海龙禧投资有限公司 A kind of hair restorer of the part containing hair stroma cell activator
FR3104972B1 (en) * 2019-12-20 2022-08-26 Oreal Process for treating keratin fibers using a composition comprising a salt of carnitine or of a carnitine derivative comprising a heterocyclic organic anion
FR3104969B1 (en) * 2019-12-20 2022-01-07 Oreal Process for treating keratin fibers using a composition comprising a salt of carnitine or of a carnitine derivative comprising an aromatic organic anion
FR3104970B1 (en) * 2019-12-20 2022-01-07 Oreal Process for treating keratin fibers using a composition comprising a salt of carnitine or of a carnitine derivative comprising an aromatic organic anion

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2144567B1 (en) * 1971-07-06 1974-03-29 Labaz
IT1206954B (en) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti THERAPEUTIC AGENTS BASED ON AN ACIL DERIVATIVE OF CARNITINE FOR THE TREATMENT OF PERIPHERAL VASCULOPATHIES
IT1116037B (en) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS AND AMIDS THEIR PREPARATION PROCEDURES AND THERAPEUTIC USE
JPS56167262A (en) 1980-05-27 1981-12-22 Citizen Watch Co Ltd Method of producing filament for microminiature bulb and tape
JPS5913710A (en) * 1982-07-15 1984-01-24 Shiseido Co Ltd Hair tonic
JPS5927809A (en) * 1982-08-10 1984-02-14 Lion Corp Hair tonic
JPS604113A (en) * 1983-06-21 1985-01-10 Lion Corp Hair tonic
JPS6341363A (en) 1986-08-07 1988-02-22 Minolta Camera Co Ltd Sorter having finisher
JPS6341364A (en) 1986-08-07 1988-02-22 Minolta Camera Co Ltd Sorter having finisher
JPH01199905A (en) * 1988-02-05 1989-08-11 Fujio Morikawa Hair tonic cosmetic
KR920702997A (en) * 1990-02-13 1992-12-17 우에하라 아끼라 New Uses of Alkalamidocarboxybetaine
AU659861B2 (en) * 1991-09-10 1995-06-01 Sansho Seiyaku Co., Ltd. Preparation for promoting hair growth
IT1254135B (en) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS WITH LONG CHAIN ALIPHATIC ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, WITH ANTIBACTERIAL ACTIVITY.
IT1254136B (en) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS WITH LONG CHAIN ALIPHATIC ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, WITH ANTI-Fungal activity.
IT1258370B (en) * 1992-03-02 1996-02-26 Sigma Tau Ind Farmaceuti ESTERS OF L-CARNITINE AND ACIL L-CARNITINE EQUIPPED WITH SELECTIVE MYO-RELAXING ACTIVITY ON THE GASTRO-INTESTINAL APPARATUS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPH0645533A (en) 1992-07-23 1994-02-18 Nec Corp Cmos type field effect semiconductor device and its manufacture
IT1263013B (en) * 1992-10-20 1996-07-23 Avantgarde Spa ESTERS OF L-CARNITINE AND ALCANOYL L-CARNITINE WITH GLYCOLIC ACID OR ITS ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH AS FOR THE TREATMENT OF SKIN DISEASES.
JPH06341363A (en) * 1993-05-31 1994-12-13 Suzuki Motor Corp Intake device of engine
JPH06341364A (en) * 1993-06-01 1994-12-13 Nippondenso Co Ltd Ignition timing control device of internal combustion
IT1261828B (en) * 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti ACIL L-CARNITINE ESTERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM FOR THE TREATMENT OF THE ENDOTOXIC SHOCK.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980001977A (en) * 1996-06-29 1998-03-30 유충식 Fermentation composition for biological treatment of food waste and composting method
KR19980035281A (en) * 1996-11-11 1998-08-05 양대윤 Manufacturing method of fertilizer using waste

Also Published As

Publication number Publication date
EP0688555A2 (en) 1995-12-27
EP0688555A3 (en) 1996-09-18
AU702532B2 (en) 1999-02-25
CN1128139A (en) 1996-08-07
CA2152091A1 (en) 1995-12-21
AU2175695A (en) 1996-01-04
US5741816A (en) 1998-04-21

Similar Documents

Publication Publication Date Title
KR960000195A (en) Hair growth agents
US5227156A (en) Use of zinc compounds to stabilize a thiazolinone preservative in an anti-dandruff shampoo
CA1302280C (en) Topical antimicrobial pharmaceutical compositions and methods
US4452732A (en) Shampoo compositions
RU2137755C1 (en) Conjugates: therapeutic compound-fatty acid
CA2114910A1 (en) Fatty acid salt pesticidal composition
US5527492A (en) Cosmetic and detergent product comprising hinokitiol and a mixture of anionic surfactant and amphoteric surfactant
CA2090920A1 (en) Opacifier for water-based compositions
CA2125408A1 (en) Drug formulations for parenteral use
AU1599092A (en) Reduction of ultra-violet photodamage with triesters of citric acid
CA2087085A1 (en) Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity
RS50911B (en) Esters of l-carnitine or alkanoiyl l-carnatines useful as cationic lipids for the interacellular delivery of pharmacologically active compounds
DE19750526A1 (en) Ascorbic acid derivatives containing cosmetic and pharmaceutical preparations
DE133795T1 (en) GABA ESTER AND GABA ANALOG ESTER.
EP0864563B1 (en) N-Acyl-hydroxy amino acid esters used to protect skin and hair
RU97107153A (en) DERIVATIVES OF COLHYCIN AND THEIR THERAPEUTIC APPLICATION
CA1188991A (en) Shampoo compositions
Wright et al. N-aminoacyl derivatives of polyene macrolide antibiotics and their esters
DE69313325D1 (en) L-Carnitine and Acyl-L-Carnitine esters, with a relaxing effect, selective for the gastrointestinal tract and pharmaceutical compositions containing them
JP3033087B2 (en) Hair restorer
DE1952057A1 (en) Preparations for treating human skin
GR3023163T3 (en) Use of esters of acyl carnitines with long-chain aliphatic alcohols in the preparation of pharmaceutical compositions having antimycotic activity
KR970704456A (en) Interleukin 5 Production Inhibitor
KR910000102A (en) Enzyme inhibitor
HUT58974A (en) Synergistic herbicidal composition comprising (quinoxalinyloxy)-phenoxypropionic acid derivative as active ingredient

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19950620

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid